Evidence map›Paper›PMID 29018167›Full record

ArticleCirculation. Arrhythmia and electrophysiology2017

Inhibition of Small-Conductance Ca

Jordi Heijman, Dobromir Dobrev

Abstract readEditorialComment
In one paragraph

Article in Circulation. Arrhythmia and electrophysiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. NaInternational journal of cardiology. Heart & vasculature · 2025
    Article
  2. Article
  3. Article
  4. Enhanced CaCirculation research · 2023
    Article
  5. Inhibition of Small-Conductance, CaFrontiers in pharmacology · 2021
    Article
  6. Small Conductance CaFrontiers in physiology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. The KFrontiers in pharmacology · 2020
    Article
  11. Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging.International journal of cardiology. Heart & vasculature · 2018
    Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jordi HeijmanFrom the Department of Cardiology, Cardiovascular Research Institute Maastricht, Faculty of Health, Medicine, and Life Sciences, Maastricht University, The Netherlands (J.H.); and Institute of Pharmacology, West German Heart and Vascular Center, School of Medicine, University Duisburg-Essen, Germany (D.D.).
Dobromir DobrevFrom the Department of Cardiology, Cardiovascular Research Institute Maastricht, Faculty of Health, Medicine, and Life Sciences, Maastricht University, The Netherlands (J.H.); and Institute of Pharmacology, West German Heart and Vascular Center, School of Medicine, University Duisburg-Essen, Germany (D.D.). dobromir.dobrev@uk-essen.de.

Funding

The Role of Inflammasome in the Pathogenesis of Atrial FibrillationR01HL136389 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Na Li · 2017 to 2026
$5.6M
Sex-specific arrhythmogenic mechanisms of atrial fibrillationR01HL131517 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Eleonora Grandi · 2016 to 2026
$5.0M
NHLBI NIH HHS R01 HL131517NHLBI NIH HHS R01 HL136389
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atrial FibrillationPotassium Channels, Calcium-ActivatedAnimalsAnisolesAnti-Arrhythmia AgentsPyrrolidinesSwineAnisolesAnti-Arrhythmia AgentsPotassium Channels, Calcium-ActivatedPyrrolidinesvernakalantatrial fibrillationcatheter ablationEditorialsmorbidityprevalencestroke

Identifiers

PMID29018167
PMCPMC5646693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.